Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
By G. Demetri, M. von Mehren, Robin L. Jones, M. Hensley, S. Schuetze, A. Staddon, M. Milhem, A. Elias, K. Ganjoo, H. Tawbi and 9 more. Journal of Clinical Oncology, 2016
691 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/db416ada300272020056a9ce75fd16bfc73eaf57
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, background): “It has proved effective in LMS and liposarcoma [38, 39].”